COMP <GO>
ACHR vs TMO // REVENUE GROWTH (YOY)
Archer Aviation Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ACHR 3
— TMO 11
▲ REVENUE GROWTH (YOY) LEADER: TMO
LAST: $4.20 (-4.11%) • MKT CAP: $3.41B
revenue-growth
-3.30%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
revenue-growth
3.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACHR VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACHR | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.30% | 41.00% | -7.70 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 9.30% | -44.30 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -15.01% | 2.40% | -17.41 | TMO | /fcf-yield <GO> |
| Operating Margin | -60.00% | 17.40% | -77.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 15.10% | -75.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -3.30% | 3.90% | -7.20 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.45 | 4.50 | +1.95 | ACHR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.70% | -0.10 | ACHR | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.9 | 59.1 | -17.26 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.94 | -0.04 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 36.3x | -18.30 | ACHR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.41B | $262.22B | -$258.81B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACHR REV | TMO REV | ACHR GROSS % | TMO GROSS % | ACHR FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $300.0K | $44.56B | 33.3% | 44.0% | -$511.7M | $6.29B |
| FY 2024 | $0 | $42.88B | — | 44.0% | -$450.6M | $7.27B |
| FY 2023 | $0 | $42.86B | — | 44.0% | -$271.6M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACHR // BETA 0.90
TMO // BETA 0.94